The ERA-EDTA Registry Annual Report 2018: a summary
Journal
Clinical Kidney Journal
Date Issued
2020-12-24
Author(s)
Kramer, Anneke
Boenink, Rianne
Stel, Vianda S
Santiuste de Pablos, Carmen
Tomović, Filip
Golan, Eliezer
Kerschbaum, Julia
Seyahi, Nurhan
Ioanou, Kyriakos
Beltrán, Palma
Zurriaga, Oscar
Magaz, Ángela
Slon Roblero, María F
Garneata, Liliana
Arribas, Federico
Galvão, Ana A
Bell, Samira
Ots-Rosenberg, Mai
Muñoz-Terol, José M
Winzeler, Rebecca
Hommel, Kristine
Åsberg, Anders
Spustova, Viera
Palencia García, María Ángeles
Vazelov, Evgueniy
Finne, Patrik
ten Dam, Marc A G J
Lopot, František
Trujillo-Alemán, Sara
Lassalle, Mathilde
Kolesnyk, Mykola O
Santhakumaran, Shalini
Idrizi, Alma
Andrusev, Anton
Comas Farnés, Jordi
Komissarov, Kirill
Resić, Halima
Palsson, Runolfur
Kuzema, Viktorija
Garcia Bazaga, Maria Angeles
Ziginskiene, Edita
Stendahl, Maria
Bonthuis, Marjolein
Massy, Ziad A
Jager, Kitty J
DOI
10.1093/ckj/sfaa271
Abstract
Background: The European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Registry collects data on kidney replacement therapy (KRT) via national and regional renal registries in Europe and countries bordering the Mediterranean Sea. This article summarizes the 2018 ERA-EDTA Registry Annual Report, and describes the epidemiology of KRT for kidney failure in 34 countries. Methods: Individual patient data on patients undergoing KRT in 2018 were provided by 34 national or regional renal registries and aggregated data by 17 registries. The incidence and prevalence of KRT, the kidney transplantation activity and the survival probabilities of these patients were calculated. Results: In 2018, the ERA-EDTA Registry covered a general population of 636 million people. Overall, the incidence of KRT for kidney failure was 129 per million population (p.m.p.), 62% of patients were men, 51% were ≥65 years of age and 20% had diabetes mellitus as cause of kidney failure. Treatment modality at the onset of KRT was haemodialysis (HD) for 84%, peritoneal dialysis (PD) for 11% and pre-emptive kidney transplantation for 5% of patients. On 31 December 2018, the prevalence of KRT was 897 p.m.p., with 57% of patients on HD, 5% on PD and 38% living with a kidney transplant. The transplant rate in 2018 was 35 p.m.p.: 68% received a kidney from a deceased donor, 30% from a living donor and for 2% the donor source was unknown. For patients commencing dialysis during 2009–13, the unadjusted 5-year survival probability was 42.6%. For patients receiving a kidney transplant within this period, the unadjusted 5-year survival probability was 86.6% for recipients of deceased donor grafts and 93.9% for recipients of living donor grafts.